Position in NVAX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,927,944
+$384,600 QoQ
Shares Held
204,665
+7.9% QoQ
Ownership
0.124%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#47
of 263 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 18%
Shared 0%
None 82%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,298,250 across 329 Biotechnology names. NVAX ranks #101 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in NVAX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,927,944 | 204,665 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,543,344 | 189,600 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,275,153 | 189,755 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,925,390 | 222,075 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,461,077 | 231,917 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,380,797 | 215,413 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $1,676,050 | 208,464 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $2,468,407 | 195,440 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,530,847 | 199,909 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $686,336 | 143,585 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $627,264 | 130,680 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $898,788 | 124,142 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $916,178 | 123,308 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $679,645 | 98,073 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $843,145 | 82,018 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,492,927 | 82,029 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $4,110,799 | 79,930 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $5,321,359 | 72,252 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $11,234,142 | 78,522 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $15,397,121 | 74,271 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $15,975,053 | 75,244 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $17,607,739 | 97,114 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $11,318,041 | 101,498 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $10,084,134 | 93,070 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $8,977,545 | 107,709 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $666,723 | 49,096 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||